Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165656 | SCV000216393 | likely benign | Hereditary cancer-predisposing syndrome | 2023-04-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000231924 | SCV000285149 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-12-08 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000412437 | SCV000489520 | uncertain significance | Lynch syndrome 4 | 2016-10-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000034634 | SCV000565388 | uncertain significance | not provided | 2023-05-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with kidney cancer and in an individual with cancer evaluated with MSI and IHC (Yehia et al., 2018; Li et al., 2020); This variant is associated with the following publications: (PMID: 22703879, 28569743, 29684080, 29570743, 32277576, 31391288, 11574484, 27600092) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001290448 | SCV000697378 | uncertain significance | not specified | 2022-09-16 | criteria provided, single submitter | clinical testing | Variant summary: PMS2 c.708G>T (p.Leu236Phe) results in a non-conservative amino acid change located in the DNA mismatch repair protein family, N-terminal domain (IPR002099) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.3e-05 in 184566 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.708G>T has been reported in the literature in individuals affected with Hereditary Nonpolyposis Colorectal Cancer or other type of cancer. These reports do not provide unequivocal conclusions about association of the variant with Hereditary Nonpolyposis Colorectal Cancer. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (likely benign n=1, VUS n=5). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Color Diagnostics, |
RCV000165656 | SCV000911382 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-15 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000412437 | SCV001137317 | uncertain significance | Lynch syndrome 4 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000412437 | SCV004019886 | uncertain significance | Lynch syndrome 4 | 2023-04-05 | criteria provided, single submitter | clinical testing | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. |
Baylor Genetics | RCV000412437 | SCV004205507 | uncertain significance | Lynch syndrome 4 | 2024-03-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005042107 | SCV005674346 | uncertain significance | Lynch syndrome 4; Mismatch repair cancer syndrome 4 | 2024-04-22 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034634 | SCV000043434 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |